Everlywell operates in the digital health sector, combining AI-powered technology with human insight to deliver personalized health answers. Its core business spans advanced diagnostics, virtual care, and patient engagement across the United States. The company's biomarker intelligence platform transforms complex biomarker data into actionable insights, having delivered close to one billion of them.
The platform powers services for hundreds of enterprise partners, including eight of the ten largest health plans in the United States. To date, the company's work has affected an estimated 60 million people. Technical domains within the organization include AI-powered technology, biomarker intelligence, and advanced diagnostics.
The firm was founded from a personal frustration with the traditional healthcare system, specifically the difficulty of lab testing. It seeks to reshape how and where health happens, integrating diagnostics with virtual care and patient engagement.
